🇺🇸 FDA
Patent

US 10538762

Allele selective inhibition of mutant C9orf72 foci expression by duplex RNAS targeting the expanded hexanucleotide repeat

granted A61KA61K31/713

Quick answer

US patent 10538762 (Allele selective inhibition of mutant C9orf72 foci expression by duplex RNAS targeting the expanded hexanucleotide repeat) held by The Board of Regents of the University of Texas System expires Mon Jan 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jan 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/713